Published in Gene Therapy Weekly, November 25th, 2004
According to recent research published in the journal Anticancer Research, "Carcinogenesis of the prostate involves androgen influences, and associations between genetic polymorphisms of androgen receptor and metabolizing enzymes and prostate cancer risk have been reported.
"Roles for non-androgenic hormones are not well defined, but they also may have an impact judging from epidemiological and animal experimental alphalambda zetaof data. The purpose of the study was to determine whether hormone-related polymorphisms are associated with prostate cancer risk."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly